Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir-experienced subjects: AIDS clinical trials group protocol 373

Roy M. Gulick, Laura M. Smeaton, Richard T. D’Aquila, Joseph J. Eron, Judith S. Currier, John G. Gerber, Edward Acosta, Jean Pierre Sommadossi, Roger Tung, Sally Snyder, Daniel R. Kuritzkes, Robert L. Murphy, Bruce Cohen, Joyce Drury, Baiba Berzins, Debra Johnson, Virgilio Clemente, Karen Cavanagh, Michelle Phillip, Ernesto G. ScerpellaAllan E. Rodriguez, Michael K. Klebert, Pablo Tebas, M. Graham Ray, Sally Canmann, Melody Pratt-Palmore, Sherree Wright, Timothy Cooley, Carolyn Koziol, Ian Frank, Christopher Helker, Linh Ngo, Nazneen Howerton, Wende Levy, Antoinette Kenton, Diane Daria, John Ioannidis, Elizabeth Adams, Ana Martinez, Anne Kmack, Mary Jo Werder, Jules Levin, Robert Curry, Marita McDonough, Patrick Robinson, Michael Stevens, Michael Rogers, Daniel Stein, Randi Leavitt, Melissa Seniuk, John Alam, Pravin Chaturvedi, Judith Partaledis

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir-experienced subjects: AIDS clinical trials group protocol 373'. Together they form a unique fingerprint.

Medicine & Life Sciences